Phase I/II Trial of Brogidirsen: Dual-Targeting Antisense Oligonucleotides for Exon 44 Skipping in Duchenne Muscular Dystrophy
Preprint in medRxiv (August 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Preprint in medRxiv (August 2024)
Article in BioDrugs (June 2024)
Article in ACS Omega (December 2023)